Atreus Pharmaceuticals Overview
- Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
Corporate
- Financing Rounds
-
2
Atreus Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company focused on developing in-vivo radiopharmaceutical products. The company develops products suitable for nuclear medicine (SPECT) imaging that aid in the early diagnosis and management of diseases including rheumatoid arthritis, helping its clients with early diagnosis and management of diseases including rheumatoid arthritis.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
- 9 Hansen Avenue
- Ottawa, Ontario K2K 2L9
- Canada
Atreus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|